Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Quality Lowdown: COVID-19's Pressures On Drug Quality

Aug 13 2020

• By Bowman Cox

The Quality Lowdown

Related Content

US FDA Invites Warning Letter Follow-Up Inspection Alternative Proposals As Pandemic Persists

Jul 01 2020

NIIMBL Aims To Help Manufacturers Perfect Next-Generation COVID-19 Vaccines

Aug 11 2020

The Quality Lowdown: Spanish Falsification, Czech Mold And Dutch Contamination Cited After EU Lull Ends

Nov 27 2019

White House Hypes Chloroquine, A Drug Currently In Shortage, As Coronavirus Treatment Hope

Mar 20 2020

Enforcement in Brief

Feb 25 2016

Blanket Warning By US FDA For Sanitizers Made By Mexico Firms Linked To Methanol Contamination

Jul 28 2020

CGMP Requirements Apply To Remdesivir In COVID-19 Emergency – But Not To Chloroquine Or HCQ

May 07 2020

Additional Topics

United States Mexico India Asia Pacific Spain Europe Quality Enforcement Compliance Coronavirus COVID-19 Manufacturing BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window